Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy | Zendy

Sjoerd A.M.E.G. Timmermans | Zendy; Myrurgia Abdul Hamid | Zendy; Jan Willem Cohen Tervaert | Zendy; Jan Damoiseaux | Zendy; Pieter van Paassen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy

Author(s) -

Sjoerd A.M.E.G. Timmermans,

Myrurgia Abdul Hamid,

Jan Willem Cohen Tervaert,

Jan Damoiseaux,

Pieter van Paassen

Publication year - 2015

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000437236

Subject(s) - medicine , hazard ratio , gastroenterology , proteinuria , antibody , membranous nephropathy , cohort , immunology , kidney , confidence interval

The natural course of idiopathic membranous nephropathy (MN) varies, as it is known through favorable outcomes in most patients. However, one third of patients with idiopathic MN will slowly progress to end-stage renal disease (ESRD). To prevent disease progression, patients at high risk to develop ESRD are treated with immunosuppressive agents. Therefore, a correct selection of patients who need immunosuppressive treatment is important.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research